Your browser doesn't support javascript.
loading
Genetic predisposition to in situ and invasive lobular carcinoma of the breast.
Sawyer, Elinor; Roylance, Rebecca; Petridis, Christos; Brook, Mark N; Nowinski, Salpie; Papouli, Efterpi; Fletcher, Olivia; Pinder, Sarah; Hanby, Andrew; Kohut, Kelly; Gorman, Patricia; Caneppele, Michele; Peto, Julian; Dos Santos Silva, Isabel; Johnson, Nichola; Swann, Ruth; Dwek, Miriam; Perkins, Katherine-Anne; Gillett, Cheryl; Houlston, Richard; Ross, Gillian; De Ieso, Paolo; Southey, Melissa C; Hopper, John L; Provenzano, Elena; Apicella, Carmel; Wesseling, Jelle; Cornelissen, Sten; Keeman, Renske; Fasching, Peter A; Jud, Sebastian M; Ekici, Arif B; Beckmann, Matthias W; Kerin, Michael J; Marme, Federick; Schneeweiss, Andreas; Sohn, Christof; Burwinkel, Barbara; Guénel, Pascal; Truong, Therese; Laurent-Puig, Pierre; Kerbrat, Pierre; Bojesen, Stig E; Nordestgaard, Børge G; Nielsen, Sune F; Flyger, Henrik; Milne, Roger L; Perez, Jose Ignacio Arias; Menéndez, Primitiva; Benitez, Javier.
  • Sawyer E; Research Oncology, Division of Cancer Studies, Kings College London, Guy's Hospital, London, United Kingdom.
  • Roylance R; Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom.
  • Petridis C; Research Oncology, Division of Cancer Studies, Kings College London, Guy's Hospital, London, United Kingdom.
  • Brook MN; Division of Genetics and Epidemiology, Institute of Cancer Research, London, United Kingdom.
  • Nowinski S; Research Oncology, Division of Cancer Studies, Kings College London, Guy's Hospital, London, United Kingdom.
  • Papouli E; Biomedical Research Centre, King's College London, Guy's Hospital, London, United Kingdom.
  • Fletcher O; Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom.
  • Pinder S; Research Oncology, Division of Cancer Studies, Kings College London, Guy's Hospital, London, United Kingdom.
  • Hanby A; Leeds Institute of Molecular Medicine, St James's University Hospital, Leeds, United Kingdom.
  • Kohut K; Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom.
  • Gorman P; Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom.
  • Caneppele M; Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom.
  • Peto J; London School of Hygiene and Tropical Medicine, London, United Kingdom.
  • Dos Santos Silva I; London School of Hygiene and Tropical Medicine, London, United Kingdom.
  • Johnson N; Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom.
  • Swann R; Department of Molecular and Applied Biosciences, University of Westminster, London, United Kingdom.
  • Dwek M; Department of Molecular and Applied Biosciences, University of Westminster, London, United Kingdom.
  • Perkins KA; Department of Molecular and Applied Biosciences, University of Westminster, London, United Kingdom.
  • Gillett C; Research Oncology, Division of Cancer Studies, Kings College London, Guy's Hospital, London, United Kingdom.
  • Houlston R; Division of Genetics and Epidemiology, Institute of Cancer Research, London, United Kingdom.
  • Ross G; The Royal Marsden NHS Foundation Trust, London, United Kingdom.
  • De Ieso P; The Royal Marsden NHS Foundation Trust, London, United Kingdom.
  • Southey MC; Department of Pathology, The University of Melbourne, Melbourne, Australia.
  • Hopper JL; Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, The University of Melbourne, Melbourne, Australia.
  • Provenzano E; NIHR Cambridge Biomedical Research Centre, Addenbrookes Hospital, Cambridge, United Kingdom.
  • Apicella C; Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, The University of Melbourne, Melbourne, Australia.
  • Wesseling J; Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
  • Cornelissen S; Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
  • Keeman R; Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
  • Fasching PA; David Geffen School of Medicine, Department of Medicine Division of Hematology and Oncology, University of California at Los Angeles, Los Angeles, California, United States of America; Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nür
  • Jud SM; Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.
  • Ekici AB; Institute of Human Genetics, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
  • Beckmann MW; Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.
  • Kerin MJ; Surgery, Clinical Science Institute, National University of Ireland, Galway, Ireland.
  • Marme F; Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany; National Center for Tumor Diseases, University of Heidelberg, Heidelberg, Germany.
  • Schneeweiss A; Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany; National Center for Tumor Diseases, University of Heidelberg, Heidelberg, Germany.
  • Sohn C; Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany.
  • Burwinkel B; Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany; Molecular Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Guénel P; Inserm (National Institute of Health and Medical Research), CESP (Center for Research in Epidemiology and Population Health), U1018, Environmental Epidemiology of Cancer, Villejuif, France; University Paris-Sud, UMRS 1018, Villejuif, France.
  • Truong T; Inserm (National Institute of Health and Medical Research), CESP (Center for Research in Epidemiology and Population Health), U1018, Environmental Epidemiology of Cancer, Villejuif, France; University Paris-Sud, UMRS 1018, Villejuif, France.
  • Laurent-Puig P; Université Paris Sorbonne Cité, UMR-S775 Inserm, Paris, France.
  • Kerbrat P; Centre Eugène Marquis, Department of Medical Oncology, Rennes, France.
  • Bojesen SE; Copenhagen General Population Study and Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, University of Copenhagen, Copenhagen, Denmark.
  • Nordestgaard BG; Copenhagen General Population Study and Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, University of Copenhagen, Copenhagen, Denmark.
  • Nielsen SF; Copenhagen General Population Study and Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, University of Copenhagen, Copenhagen, Denmark.
  • Flyger H; Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark.
  • Milne RL; Genetic & Molecular Epidemiology Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre [CNIO], Madrid, Spain.
  • Perez JI; Servicio de Cirugía General y Especialidades, Hospital Monte Naranco, Oviedo, Spain.
  • Menéndez P; Servicio de Anatomía Patológica, Hospital Monte Naranco, Oviedo, Spain.
  • Benitez J; Human Genetics Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre [CNIO], Madrid, Spain.
PLoS Genet ; 10(4): e1004285, 2014 04.
Article en En | MEDLINE | ID: mdl-24743323

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Carcinoma in Situ / Carcinoma Lobular / Predisposición Genética a la Enfermedad Tipo de estudio: Observational_studies / Risk_factors_studies / Systematic_reviews Límite: Female / Humans / Middle aged Idioma: En Año: 2014 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Carcinoma in Situ / Carcinoma Lobular / Predisposición Genética a la Enfermedad Tipo de estudio: Observational_studies / Risk_factors_studies / Systematic_reviews Límite: Female / Humans / Middle aged Idioma: En Año: 2014 Tipo del documento: Article